Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06321471 · ClinicalTrials.gov registry record · NA
AeviceMD for Pediatric Asthma Management
A NA study of Asthma and Asthma in Children, sponsored by Irina Dralyuk.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06321471: Recruiting NA study of Asthma and Asthma in Children, sponsored by Irina Dralyuk.
NCT06321471 is a NA study of Asthma and Asthma in Children that is actively recruiting participants, run by Irina Dralyuk. The registered enrollment target is 20 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06321471, a NA study of Asthma and Asthma in Children, is actively recruiting participants, sponsored by Irina Dralyuk.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
A wearable remote patient monitor (AeviceMD) is to be used to monitor the respiratory health of pediatric asthma patients in this pilot study. Patients prescribed with AeviceMD should be able to gain better control over their disease during home management. Physicians should be able to optimize treatment for these patients using objective data collected from and of these patients outside of the clinic. The AeviceMD should also be used as a remote auscultation device for teleconsultations.
Primary Outcome
The study primary objectives are met if enrolled patients achieve better manage of their asthma shown by a reduction in admission rate, improvement in patient satisfaction, and quality of life. For this purpose, the Pediatric Asthma Control and Communication Instrument (PACCI) system will be utilized. This is a 12-item questionnaire resulting in a sum score ranging from 0 (best asthma control) to 19 (worst asthma control). A decrease in the sum score indicates an improvement in asthma control.
Conditions Studied
Interventions
- DEVICE AeviceMD
Study Locations (1)
California
- Cedars-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-11-05 |
| Est. Completion | 2026-02 |
| Phase | NA |
What NCT06321471 shows while recruiting
NCT06321471 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which AeviceMD is the first listed.
NCT06321471 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06321471 about?
NCT06321471 is a clinical study titled "AeviceMD for Pediatric Asthma Management". A wearable remote patient monitor (AeviceMD) is to be used to monitor the respiratory health of pediatric asthma patients in this pilot study. Patients prescribed with AeviceMD should be able to gain better control over their disease during home management. Physicians should be able to optimize trea...
What is the current status of trial NCT06321471?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-11-05. Estimated completion is 2026-02.
What conditions does trial NCT06321471 study?
This clinical trial studies the following conditions: Asthma, Asthma in Children, Pediatric Asthma, Chronic Respiratory Disease.
What interventions are being tested in trial NCT06321471?
The interventions under investigation include: AeviceMD (DEVICE).
Who is sponsoring clinical trial NCT06321471?
This trial is sponsored by Irina Dralyuk, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06321471 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06321471's enrollment target sits among peer trials
20 338th of 374 higher than 30 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI